Norwegian Man Cured of HIV
Analysis based on 6 articles · First reported Apr 13, 2026 · Last updated Apr 23, 2026
This medical breakthrough, while not directly impacting stock prices of specific companies due to its rarity, could positively influence the biotechnology and healthcare sectors by demonstrating the potential for advanced therapies. It may also spur further research and investment into gene-editing and stem cell technologies for treating chronic diseases.
A 63-year-old Norwegian man, dubbed the 'Oslo patient', has been effectively cured of HIV after receiving a stem cell transplant from his brother at Oslo University Hospital in 2020. The brother was found to carry a rare, virus-blocking CCR5 genetic mutation, which was discovered on the day of the transplant. The patient had been living with HIV since 2006 and was diagnosed with myelodysplastic syndrome, a fatal blood cancer, in 2017. Two years after the transplant, the patient stopped antiretroviral drugs, and researchers, including Anders Eivind Myhre and Marius Trøseid, found no trace of the virus. This case is significant as it is the first time a family member has been the donor for such a cure, adding to a small number of individuals worldwide, including Timothy Ray Brown, who have achieved long-term remission from HIV through similar procedures for blood cancer.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard